Dmitry Balyasny’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,471
Closed -$200K 3528
2026
Q1
$200K Sell
11,471
-19,285
-63% -$383K ﹤0.01% 2706
2025
Q4
$604K Buy
+30,756
New +$638K ﹤0.01% 2438
2024
Q1
Sell
-13,934
Closed -$747K 3148
2023
Q4
$747K Buy
+13,934
New +$705K ﹤0.01% 1801
2023
Q2
Sell
-13,091
Closed -$823K 2823
2023
Q1
$823K Buy
+13,091
New +$781K ﹤0.01% 1809
2022
Q2
Sell
-9,765
Closed -$776K 3210
2022
Q1
$776K Buy
+9,765
New +$880K ﹤0.01% 1702
2021
Q3
Sell
-8,354
Closed -$856K 2447
2021
Q2
$856K Buy
8,354
+3,954
+90% +$397K ﹤0.01% 1358
2021
Q1
$429K Buy
+4,400
New +$400K ﹤0.01% 1440
2020
Q1
Sell
-22,602
Closed -$1.77M 1543
2019
Q4
$1.77M Buy
22,602
+7,894
+54% +$582K 0.01% 778
2019
Q3
$1.01M Buy
+14,708
New +$988K 0.01% 833
2019
Q2
Sell
-8,225
Closed -$690K 1746
2019
Q1
$690K Buy
+8,225
New +$859K ﹤0.01% 1118
2017
Q4
Sell
-5,250
Closed -$303K 2337
2017
Q3
$303K Buy
+5,250
New +$310K ﹤0.01% 1532

Other funds holding USNA

Dmitry Balyasny's USNA Position: Q2 2026 in Review

Dmitry Balyasny sold out of Usana Health Sciences (USNA) in Q2 2026, closing a stake of 11,471 shares — an estimated $200K sold.

Dmitry Balyasny first reported a position in USNA in Q3 2017 and held it in 11 quarters. The position peaked at $1.77M in Q4 2019. 137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Dmitry Balyasny reported no remaining Usana Health Sciences position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 11,471 Usana Health Sciences shares in Q2 2026, an estimated $200K.
  • Dmitry Balyasny first reported a position in Usana Health Sciences in Q3 2017 and held it in 11 quarters.
  • Dmitry Balyasny's Usana Health Sciences position peaked at $1.77M in Q4 2019.
  • 137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.